672 related articles for article (PubMed ID: 24486372)
1. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available.
Ishikawa T; Yamanaka A; Konishi E
Vaccine; 2014 Mar; 32(12):1326-37. PubMed ID: 24486372
[TBL] [Abstract][Full Text] [Related]
2. Flaviviruses and flavivirus vaccines.
Heinz FX; Stiasny K
Vaccine; 2012 Jun; 30(29):4301-6. PubMed ID: 22682286
[TBL] [Abstract][Full Text] [Related]
3. T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.
Grifoni A; Voic H; Dhanda SK; Kidd CK; Brien JD; Buus S; Stryhn A; Durbin AP; Whitehead S; Diehl SA; De Silva AD; Balmaseda A; Harris E; Weiskopf D; Sette A
J Virol; 2020 May; 94(10):. PubMed ID: 32132233
[TBL] [Abstract][Full Text] [Related]
4. Current status of flavivirus vaccines.
Barrett AD
Ann N Y Acad Sci; 2001 Dec; 951():262-71. PubMed ID: 11797783
[TBL] [Abstract][Full Text] [Related]
5. Dengue and other emerging flaviviruses.
Solomon T; Mallewa M
J Infect; 2001 Feb; 42(2):104-15. PubMed ID: 11531316
[TBL] [Abstract][Full Text] [Related]
6. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.
Lai CJ; Monath TP
Adv Virus Res; 2003; 61():469-509. PubMed ID: 14714441
[TBL] [Abstract][Full Text] [Related]
7. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
[TBL] [Abstract][Full Text] [Related]
8. New developments in flavivirus vaccines with special attention to yellow fever.
Pugachev KV; Guirakhoo F; Monath TP
Curr Opin Infect Dis; 2005 Oct; 18(5):387-94. PubMed ID: 16148524
[TBL] [Abstract][Full Text] [Related]
9. Advances in flavivirus vaccine development.
Coller BA; Clements DE; Martyak T; Yelmene M; Thorne M; Parks DE
IDrugs; 2010 Dec; 13(12):880-4. PubMed ID: 21154147
[TBL] [Abstract][Full Text] [Related]
10. Emerging vector-borne flavivirus diseases: are vaccines the solution?
Gubler DJ
Expert Rev Vaccines; 2011 May; 10(5):563-5. PubMed ID: 21604976
[No Abstract] [Full Text] [Related]
11. Recent advancement in flavivirus vaccine development.
Chang GJ; Kuno G; Purdy DE; Davis BS
Expert Rev Vaccines; 2004 Apr; 3(2):199-220. PubMed ID: 15056045
[TBL] [Abstract][Full Text] [Related]
12. [Flavivirus infections: yellow fever, dengue fever and Japanese encephalitis].
Buhl MR
Ugeskr Laeger; 2005 Oct; 167(43):4076-80. PubMed ID: 16251091
[TBL] [Abstract][Full Text] [Related]
13. Traditional and novel approaches to flavivirus vaccines.
Pugachev KV; Guirakhoo F; Trent DW; Monath TP
Int J Parasitol; 2003 May; 33(5-6):567-82. PubMed ID: 12782056
[TBL] [Abstract][Full Text] [Related]
14. Live flavivirus vaccines: reasons for caution.
Seligman SJ; Gould EA
Lancet; 2004 Jun; 363(9426):2073-5. PubMed ID: 15207960
[TBL] [Abstract][Full Text] [Related]
15. Research advances in plant-made flavivirus antigens.
Martínez CA; Giulietti AM; Talou JR
Biotechnol Adv; 2012; 30(6):1493-505. PubMed ID: 22480936
[TBL] [Abstract][Full Text] [Related]
16. Mucosal Vaccination: A Promising Alternative Against Flaviviruses.
Luria-Pérez R; Sánchez-Vargas LA; Muñoz-López P; Mellado-Sánchez G
Front Cell Infect Microbiol; 2022; 12():887729. PubMed ID: 35782117
[TBL] [Abstract][Full Text] [Related]
17. A Perspective on Current Flavivirus Vaccine Development: A Brief Review.
Dutta SK; Langenburg T
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112840
[TBL] [Abstract][Full Text] [Related]
18. Flavivirus DNA vaccines: current status and potential.
Chang GJ; Davis BS; Hunt AR; Holmes DA; Kuno G
Ann N Y Acad Sci; 2001 Dec; 951():272-85. PubMed ID: 11797784
[TBL] [Abstract][Full Text] [Related]
19. Mouse and hamster models for the study of therapy against flavivirus infections.
Charlier N; De Clercq E; Neyts J
Novartis Found Symp; 2006; 277():218-29; discussion 229-32, 251-3. PubMed ID: 17319165
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial.
Sandberg JT; Löfling M; Varnaitė R; Emgård J; Al-Tawil N; Lindquist L; Gredmark-Russ S; Klingström J; Loré K; Blom K; Ljunggren HG
PLoS Negl Trop Dis; 2023 Feb; 17(2):e0010616. PubMed ID: 36758067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
